IRIS
BERTONI, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.899
AS - Asia 6.823
EU - Europa 6.023
SA - Sud America 870
AF - Africa 388
Continente sconosciuto - Info sul continente non disponibili 193
OC - Oceania 6
Totale 26.202
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.551
SG - Singapore 2.346
CN - Cina 2.012
IT - Italia 1.145
VN - Vietnam 1.047
FI - Finlandia 975
SE - Svezia 820
IE - Irlanda 800
BR - Brasile 665
DE - Germania 599
UA - Ucraina 463
HK - Hong Kong 449
GB - Regno Unito 256
FR - Francia 248
ZA - Sudafrica 242
NL - Olanda 238
BD - Bangladesh 230
CA - Canada 208
TR - Turchia 194
IN - India 140
RU - Federazione Russa 114
BE - Belgio 73
AR - Argentina 71
CI - Costa d'Avorio 65
ES - Italia 60
MX - Messico 53
AT - Austria 49
JP - Giappone 46
CZ - Repubblica Ceca 42
TH - Thailandia 41
EC - Ecuador 38
PH - Filippine 37
IQ - Iraq 35
KR - Corea 34
PK - Pakistan 34
ID - Indonesia 33
PL - Polonia 30
CO - Colombia 26
VE - Venezuela 22
RO - Romania 20
LT - Lituania 18
EU - Europa 17
MA - Marocco 17
MY - Malesia 17
TW - Taiwan 17
CR - Costa Rica 15
JM - Giamaica 15
EG - Egitto 14
PY - Paraguay 12
CL - Cile 11
PA - Panama 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 10
ET - Etiopia 10
KE - Kenya 10
HN - Honduras 9
HU - Ungheria 9
IR - Iran 9
NI - Nicaragua 9
PT - Portogallo 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
NP - Nepal 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
JO - Giordania 7
LB - Libano 7
PE - Perù 7
AL - Albania 6
IL - Israele 6
UY - Uruguay 6
BG - Bulgaria 5
DK - Danimarca 5
DZ - Algeria 5
EE - Estonia 5
HR - Croazia 5
KZ - Kazakistan 5
OM - Oman 5
SC - Seychelles 5
AU - Australia 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
MD - Moldavia 4
PS - Palestinian Territory 4
QA - Qatar 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
CH - Svizzera 3
GP - Guadalupe 3
LY - Libia 3
PR - Porto Rico 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AO - Angola 2
BN - Brunei Darussalam 2
CM - Camerun 2
CY - Cipro 2
Totale 26.003
Salva come PNG Salva come JPEG
Città #
Dallas 2.940
Singapore 1.275
Ashburn 1.044
San Jose 860
Dublin 798
Chandler 789
Santa Clara 645
Jacksonville 495
Beijing 475
Hong Kong 415
Ann Arbor 383
Dearborn 376
Ho Chi Minh City 325
Parma 320
Boardman 291
Council Bluffs 255
Johannesburg 230
New York 227
Hanoi 214
Nanjing 187
Los Angeles 176
Munich 176
Shanghai 158
Izmir 154
Princeton 138
Lauterbourg 136
Wilmington 107
Hefei 91
Toronto 91
San Mateo 90
Helsinki 84
Buffalo 79
São Paulo 68
Abidjan 65
Hebei 64
Brussels 63
Nanchang 62
Kunming 60
Washington 60
Bremen 55
Guangzhou 55
Jinan 54
Chicago 53
Milan 53
Moscow 53
Shenyang 50
Frankfurt am Main 49
Haiphong 48
Woodbridge 45
Bologna 43
Changsha 43
Montreal 42
London 41
Seattle 40
Da Nang 39
Vienna 38
Des Moines 37
Phoenix 37
Tokyo 35
Groningen 33
Tianjin 33
Brooklyn 31
Columbus 30
Turku 30
Rome 29
Amsterdam 28
Marseille 28
Bangalore 27
Grafing 27
Reggio Emilia 27
Orem 25
Atlanta 24
Auburn Hills 24
Fremont 24
Norwalk 24
Brno 23
Houston 23
Rio de Janeiro 22
Warsaw 22
Denver 21
Hangzhou 21
Jiaxing 21
Zhengzhou 20
Naples 19
Manchester 18
Modena 18
Bangkok 17
Curitiba 17
Guayaquil 17
Hải Dương 17
Mexico City 17
Nuremberg 17
Stockholm 17
Chennai 16
Belo Horizonte 15
Boston 15
Brescia 15
Jakarta 15
Madrid 15
North Bergen 15
Totale 16.273
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.729
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.658
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 271
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 265
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 249
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 248
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 245
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 234
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 234
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 229
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 218
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 214
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 213
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 208
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 208
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 205
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 203
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 203
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 201
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 196
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 195
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 194
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 190
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 188
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 188
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 187
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 186
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 185
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 185
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 183
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 183
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 181
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 180
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 179
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 178
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 177
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 177
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 176
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 174
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 172
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 172
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 171
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 169
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 169
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 169
Analgesic activity of new hybrid muscarinic agonists in mice 169
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 167
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 166
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 166
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 166
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 165
Motor responses of rat hypertrophic intestine following chronic obstruction 165
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 165
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 165
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth 163
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 163
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 162
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats 162
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA 159
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 159
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 159
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 158
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 157
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice 156
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 156
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 156
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 155
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 154
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditions 153
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 153
CNS access of selected H3-antagonists: ex vivo binding study in rats 151
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 151
Influence of gender in the mesenteric ischemia/reperfusion model in mice 150
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 149
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 149
Heterogeneous response of colonoid-derived monolayers to TNFa and IFNg exposure: functional and morphological characterization 148
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 148
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 148
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 147
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 146
Up-regulation of inhibitory transmitters in myenteric neurons of the rat ileum in an acute model of ischemia/reperfusion 145
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 144
Effects of CCL20/CCR6 modulators in a T cell adoptive transfer model of colitis 143
RESPONSIVENESS OF LONGITUDINAL AND CIRCULAR MUSCLE TO RELAXING MEDIATORS IS DIFFERENTIALLY AFFECTED IN RAT HYPERTROPHIED ILEUM 142
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 142
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 141
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 140
Role of Glutamate- N-methyl-D-Aspartate (NMDA) Receptors in Neuronal Plasticity and Gastrointestinal Transit Delay Induced by Ischemia/Reperfusion in Rats 140
Evidence for the involvement of 5-HT(2A) receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice 138
Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury 138
Synthesis and Biological Evaluation of N-Pyrazolyl-N'-alkyl/benzyl/phenylureas: a New Class of Potent Inhibitors of Interleukin 8-Induced Neutrophil Chemotaxis 137
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 136
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 133
Involvement of 5-HT2A receptors in motor and inflammatory disorders induced by mesenteric ischemia reperfusion in mice 133
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 132
Screening di nuovi agenti antiinfiammatori/antiaggreganti non-acidici: sviluppo di 2-amino-5H-[1]benzopirano[4,3-d]pirimidine 5-alchil/cicloalchilamino sostituite prive di attivita' gastrolesiva 131
Beneficial effects of blocking EphBs-ephrinBs forward signalling in a murine Crohn’s sisease (CD) model 131
Interactions of new and conventional H3-blockers with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum 131
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 130
Allosteric Modulation of Muscarinic Acetylcholine-Receptors: Oxotremorine-Phthalimidoalkyl-Hybrids of the Hexamethonio-type 129
Totale 20.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022749 0 0 0 91 51 56 94 104 33 58 58 204
2022/20233.122 346 318 179 234 318 342 67 174 926 45 120 53
2023/20241.222 69 80 45 45 88 312 125 84 38 66 97 173
2024/20253.707 137 192 259 236 382 427 155 164 396 365 271 723
2025/202610.774 840 1.235 2.824 793 1.124 474 866 280 1.141 648 333 216
2026/20271.521 204 453 473 391 0 0 0 0 0 0 0 0
Totale 26.202